WallStSmart

Graham Holdings Co (GHC)vsHarte Hanks Inc (HHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Graham Holdings Co generates 3178% more annual revenue ($5.07B vs $154.63M). GHC leads profitability with a 10.7% profit margin vs -3.7%. HHS appears more attractively valued with a PEG of 1.19. GHC earns a higher WallStSmart Score of 68/100 (B-).

GHC

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 6.0Value: 4.7Quality: 8.0
Piotroski: 4/9Altman Z: 3.17

HHS

Avoid

33

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 4.3Quality: 5.5
Piotroski: 3/9Altman Z: 14.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GHCSignificantly Overvalued (-25.1%)

Margin of Safety

-25.1%

Fair Value

$886.88

Current Price

$1138.57

$251.69 premium

UndervaluedFair: $886.88Overvalued
HHSSignificantly Overvalued (-54.3%)

Margin of Safety

-54.3%

Fair Value

$1.86

Current Price

$4.20

$2.34 premium

UndervaluedFair: $1.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GHC5 strengths · Avg: 9.8/10
P/E RatioValuation
9.1x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
676.0%10/10

Earnings expanding 676.0% YoY

Altman Z-ScoreHealth
3.1710/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.289/10

Conservative balance sheet, low leverage

HHS2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
14.4910/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

GHC2 concerns · Avg: 2.5/10
Return on EquityProfitability
6.3%3/10

ROE of 6.3% — below average capital efficiency

PEG RatioValuation
4.042/10

Expensive relative to growth rate

HHS4 concerns · Avg: 2.8/10
Market CapQuality
$31.61M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.573/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-5.2%2/10

ROE of -5.2% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : GHC

The strongest argument for GHC centers on P/E Ratio, Price/Book, EPS Growth.

Bull Case : HHS

The strongest argument for HHS centers on Altman Z-Score, Price/Book. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bear Case : GHC

The primary concerns for GHC are Return on Equity, PEG Ratio.

Bear Case : HHS

The primary concerns for HHS are Market Cap, Debt/Equity, Piotroski F-Score. Debt-to-equity of 1.57 is elevated, increasing financial risk.

Key Dynamics to Monitor

GHC profiles as a value stock while HHS is a turnaround play — different risk/reward profiles.

GHC carries more volatility with a beta of 0.71 — expect wider price swings.

GHC is growing revenue faster at 7.1% — sustainability is the question.

GHC generates stronger free cash flow (33M), providing more financial flexibility.

Bottom Line

GHC scores higher overall (68/100 vs 33/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Graham Holdings Co

INDUSTRIALS · CONGLOMERATES · USA

Graham Holdings Company is a diversified global media and education company. The company is headquartered in Arlington, Virginia.

Visit Website →

Harte Hanks Inc

INDUSTRIALS · CONGLOMERATES · USA

Harte Hanks, Inc. is a customer experience company in the United States and internationally. The company is headquartered in Chelmsford, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?